Pulmonary artery pressure technologies for remote monitoring of chronic heart failure (HTG769)Product type:GuidanceProgramme:HealthTech guidancePublished: 5 February 2026
Chronic heart failure in adults: diagnosis and management (NG106)Product type:GuidanceProgramme:NICE guidelineLast updated: 3 September 2025Published: 12 September 2018
Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices (HTG730)Product type:GuidanceProgramme:HealthTech guidancePublished: 24 October 2024
Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction (TA929)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 1 November 2023
Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction (TA902)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 21 June 2023
TYRX Absorbable Antibacterial Envelope for preventing infection from cardiac implantable electronic devices (terminated appraisal) (TA790)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 May 2022
Empagliflozin for treating chronic heart failure with reduced ejection fraction (TA773)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 9 March 2022
Acute heart failure: diagnosis and management (CG187)Product type:GuidanceProgramme:Clinical guidelineLast updated: 17 November 2021Published: 8 October 2014
Vericiguat for treating chronic heart failure with reduced ejection fraction (terminated appraisal) (TA731)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 29 September 2021
Dapagliflozin for treating chronic heart failure with reduced ejection fraction (TA679)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 February 2021
Sacubitril valsartan for treating symptomatic chronic heart failure with reduced ejection fraction (TA388)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 April 2016
Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failure (TA314)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 25 June 2014
Ivabradine for treating chronic heart failure (TA267)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 November 2012
The OPTIMIZER smart system for managing heart failure (MIB186)Product type:AdviceProgramme:Medtech innovation briefingPublished: 27 June 2019
Remote ECG interpretation consultancy services for cardiovascular disease (MIB152)Product type:AdviceProgramme:Medtech innovation briefingPublished: 27 July 2018
CentriMag for heart failure (MIB92)Product type:AdviceProgramme:Medtech innovation briefingPublished: 18 January 2017
The AutoPulse non-invasive cardiac support pump for cardiopulmonary resuscitation (MIB18)Product type:AdviceProgramme:Medtech innovation briefingPublished: 12 February 2015
Chronic heart failure in adults (QS9)Product type:Quality standardLast updated: 3 September 2025Published: 29 June 2011